Halozyme Therapeutics
HALO
$45.39
Share price
-0.94%
Change (1 day)
33.89%
Change (1 year)
Categories
Earnings for Halozyme Therapeutics (HALO)
Earnings in 2023 (TTM): $0.34 B
According to Halozyme Therapeutics's latest financial reports the company's current earnings (TTM) are $0.34 B. In 2022 the company made an earning of $0.24 B an increase over its 2021 earnings that were of $0.24 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Halozyme Therapeutics from 2002 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | $0.34 B | 39.94% |
| 2022 | $0.24 B | 0.16% |
| 2021 | $0.24 B | 92.2% |
| 2020 | $0.12 B | -278.96% |
| 2019 | -$72.26 M | -9.45% |
| 2018 | -$79.8 M | -229.51% |
| 2017 | $61.61 M | -160.48% |
| 2016 | -$0.11 B | 216.03% |
| 2015 | -$32.24 M | -52.86% |
| 2014 | -$68.38 M | -18.09% |
| 2013 | -$83.48 M | 55.88% |
| 2012 | -$53.56 M | 169.94% |
| 2011 | -$19.84 M | -63.44% |
| 2010 | -$54.26 M | -7.19% |
| 2009 | -$58.46 M | 15.91% |
| 2008 | -$50.44 M | 83.89% |
| 2007 | -$27.43 M | 78.1% |
| 2006 | -$15.41 M | 16% |
| 2005 | -$13.28 M | 45.24% |
| 2004 | -$9.15 M | 682.42% |
| 2003 | -$1.17 M | 1659.12% |
| 2002 | -$0.07 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | 6,032.99% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | 837.91% | 🇺🇸 USA |
 Eli Lilly LLY | $7.56 B | 2,070.65% | 🇺🇸 USA |
 Sanofi SNY | $7.26 B | 1,984.47% | 🇫🇷 France |
 Baxter BAX | -$1 M | -100.29% | 🇺🇸 USA |
 MannKind Corp MNKD | -$10.38 M | -102.98% | 🇺🇸 USA |